Securities Code: 001309 Securities Abbreviation: Demingli Announcement No.: 2026-025 Shenzhen Demingli Technology Co., Ltd. Announcement on Progress of Guarantees for Wholly-Owned Subsidiary The Company and the entire Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, and contains no false records, misleading statements, or major omissions. Special Risk Warning:
- As of the disclosure date of this announcement, Shenzhen Demingli Technology Co., Ltd. (hereinafter referred to as the "Company") has provided guarantees for its wholly-owned subsidiary Derma (Hong Kong) Co., Ltd. (hereinafter referred to as "Derma"), whose asset-liability ratio exceeds 70%. The cumulative amount of guaranteed contracts is USD 20,000 million and RMB 155,000 million. Calculated at the mid-price exchange rate of USD to RMB of 6.8975 on March 19, 2026, this is equivalent to RMB 292,950.00 million. The cumulative actual amount of external guarantees provided by the Company is equivalent to RMB 97,520.53 million, accounting for 29.83% of the Company's audited net assets in 2025. The aforementioned guarantees are all provided by the Company for its wholly-owned subsidiary Derma.
- The Company and its subsidiaries have no external guarantee matters outside the scope of the consolidated financial statements, nor are there any overdue guarantees. Investors are kindly requested to pay close attention to the guarantee risks. I. Internal Decision-Making Procedures and Disclosure of Guarantees Provided by the Company for Derma
- On February 26, 2026, the Company held the 38th meeting of the Second Board of Directors, which deliberated and passed the "Proposal on the Estimated Guarantee Limit for the Company in 2026". To meet the Company's daily operating and business development needs in 2026, the Company plans to provide a total guarantee limit of no more than RMB 5,000 million (or equivalent foreign currency) for its wholly-owned subsidiary Derma. This guarantee is intended to facilitate Derma's application for comprehensive credit lines from financial institutions or for other daily operating needs. The guarantee methods include, but are not limited to, guarantees, mortgages, and pledges. The estimated validity period of this guarantee limit is from the date this proposal is approved by the Company's shareholders' meeting until the day before the 2026 annual shareholders' meeting. The guarantee limit can be used repeatedly within its validity period. The guarantee methods, guarantee amounts, guarantee periods, guarantee fees, and other important terms in the guarantee agreement shall be determined through negotiation between the Company, Derma, and the relevant creditors within the aforementioned limit, and relevant agreements shall be signed or guarantee letters shall be issued. The relevant guarantee matters shall be subject to the officially signed guarantee documents. This guarantee limit within the estimated amount will not be submitted to the Board of Directors for approval on a case-by-case basis. At the same time, to improve work efficiency and expedite guarantee processing, the shareholders' meeting is requested to authorize Mr. Li Hu, the Chairman and Legal Representative, to decide on guarantee matters and sign relevant guarantee agreements and other legal documents within the estimated guarantee limit based on Derma's actual operating capital needs. The authorization period is from the date this estimated guarantee limit is approved by the Company's 2025 annual shareholders' meeting until the day before the 2026 annual shareholders' meeting. For detailed content, please refer to the announcement "Proposal on the Estimated Guarantee Limit for the Company in 2026" disclosed by the Company on February 27, 2026, on designated information disclosure media and the Giant Information Network (http://www.cninfo.com.cn).
- On March 20, 2026, the Company held its 2025 annual shareholders' meeting, which deliberated and passed the "Proposal on the Estimated Guarantee Limit for the Company in 2026". For detailed content, please refer to the announcement "2025 Annual Shareholders' Meeting Resolution Announcement" disclosed by the Company on March 21, 2026, on designated information disclosure media and the Giant Information Network (http://www.cninfo.com.cn). II. Progress of Guarantees Provided by the Company for Derma
- Derma, for its production and operation needs, signed a "Sales Contra